Teva to Pay Record $225M for Role in Antitrust Cartel; Glenmark to Pay $30M
Teva Pharmaceuticals USA, a U.S. affiliate of Teva Pharmaceutical Industries, will pay a $225 million criminal penalty—the largest to date for a domestic antitrust cartel—while Glenmark Pharmaceuticals USA will pay a $30 million criminal penalty to resolve similar criminal antitrust charges, the Department of Justice announced Aug. 21. Both Teva Read More